ChristinaSChuMD
Obstetrics & Gynecology • Camden, NJGynecologic Oncology
Attending Physician, Gynecologic Cancer, MD Anderson Cancer Center at Cooper
Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2 Cooper Plaza
Camden, NJ
Camden, NJ 08103Phone+1 856-735-6209- Is this information wrong?
Summary
- Dr. Christina Chu is a gynecologic oncologist in Camden, NJ and is affiliated with MD Anderson Cancer Center at Cooper. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 22 years. She specializes in gynecologic oncology and is experienced in the multidisciplinary treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers and preinvasive disease. Her practice encompasses surgical treatment as well as administration of chemotherapy, as well as clinical trials for cancer treatment. She has more than 60 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 1999 - 2002- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1995 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
NJ State Medical License 2004 - 2025
PA State Medical License 1996 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Ovarian Cancer and Immune Response to Flu Vaccine Start of enrollment: 2006 Oct 01
- Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients Start of enrollment: 2005 Aug 01
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- Perceived importance of weight loss and exercise among endometrial cancer survivors with overweight or obesity: Implications for lifestyle modification interventions.Tagai, E., Belfiglio, A., Lapitan, E., Santos, H., Sarwer, D., Miller, S., Mantia-Smaldone, G., Chu, C., Hernandez, E.> ;Obesity Science & Practice. 2023 Dec 1
- 2 citationsMolecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma.Sarah A Ackroyd, David Arguello, Pilar Ramos, Haider Mahdi, Adam ElNaggar, Ira Winer, Rob Holloway, Thomas Krivak, Nathaniel Jones, Valerie Galvan Turner, Thomas Herzo...> ;Gynecologic Oncology. 2023 Feb 1
- 8 citationsGenomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy.Adam ElNaggar, David Robins, Yasmine Baca, David Arguello, Michael Ulm, Rebecca Arend, Gina Mantia-Smaldone, Christina Chu, Ira Winer, Rob Holloway, Tom Krivak, Nathan...> ;Gynecologic Oncology. 2022 Nov 1
- Join now to see all
Press Mentions
Temple Physicians Learn Mindfulness to Cope with the Trauma of Treating COVIDJuly 4th, 2021
HPV in Pregnant Women Linked to Miscarriages & Preterm Births, Study ShowsMarch 5th, 2020
HPV Tied to Miscarriages and Preterm BirthsMarch 4th, 2020- Join now to see all
Hospital Affiliations
Cooper University Health CareCamden, New Jersey
External Links
- Christina Chu MD, Fox Chase Cancer Centerhttps://www.foxchase.org/christina-chu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
